Keyphrases
Hypoactive Sexual Desire Disorder
100%
Flibanserin
100%
Female Sexual Distress Scale-Revised
66%
Placebo
55%
Female Sexual Function Index
55%
Postmenopausal Women
33%
Domain Scores
33%
Sexual Event
33%
Adverse Events
22%
Change from Baseline
22%
Low Sexual Desire
22%
Interpersonal Problems
11%
Randomized Placebo-controlled Trial
11%
Dizziness
11%
Safety Concerns
11%
Nausea
11%
Sexual Desire
11%
Bedtime
11%
Once-daily
11%
Sexual Dysfunction
11%
Somnolence
11%
Mean Standard Deviation
11%
5-HT2A Antagonist
11%
5-HT1A Agonist
11%
Pharmacology, Toxicology and Pharmaceutical Science
Flibanserin
100%
Placebo
66%
Adverse Event
22%
Dizziness
11%
Nausea
11%
Somnolence
11%
Serotonin 1A Agonist
11%
Serotonin 2A Antagonist
11%
Medicine and Dentistry
Serotonin 1A Agonist
11%
Serotonin 2A Antagonist
11%